Walgreens Boots Alliance (BOVESPA:WGBA34) - Stock Price, News & Analysis

WGBA34 Stock Overview

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.

About the company

WGBA34 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	3/6
Past Performance	0/6
Financial Health	1/6
Dividends	1/6

Rewards

Trading at 52.2% below our estimate of its fair value

Earnings are forecast to grow 72.79% per year

Trading at good value compared to peers and industry

Risk Analysis

Interest payments are not well covered by earnings

Dividend of 5.6% is not well covered by earnings or cash flows

Walgreens Boots Alliance, Inc. Competitors

Raia Drogasil

BOVESPA:RADL3

R$45.2b

Dimed Distribuidora de Medicamentos

BOVESPA:PNVL3

R$1.8b

Empreendimentos Pague Menos

BOVESPA:PGMN3

R$1.5b

Atacadão

BOVESPA:CRFB3

R$25.4b

Price History & Performance

Summary of all time highs, changes and price drops for Walgreens Boots Alliance
Historical stock prices
Current Share Price	US$45.90
52 Week High	US$89.01
52 Week Low	US$45.46
Beta	0.75
1 Month Change	-10.26%
3 Month Change	-20.31%
1 Year Change	-47.00%
3 Year Change	-69.19%
5 Year Change	n/a
Change since IPO	-57.39%

Recent updates

Shareholder Returns

	WGBA34	BR Consumer Retailing	BR Market
7D	-5.1%	-2.4%	-1.0%
1Y	-47.0%	4.8%	12.7%

Return vs Industry: WGBA34 underperformed the BR Consumer Retailing industry which returned 6.7% over the past year.

Return vs Market: WGBA34 underperformed the BR Market which returned 14.1% over the past year.

Price Volatility

Is WGBA34's price volatile compared to industry and market?
WGBA34 volatility
WGBA34 Average Weekly Movement	5.2%
Consumer Retailing Industry Average Movement	4.8%
Market Average Movement	4.6%
10% most volatile stocks in BR Market	8.3%
10% least volatile stocks in BR Market	2.3%

Stable Share Price: WGBA34's share price has been volatile over the past 3 months.

Volatility Over Time: WGBA34's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1909	268,500	Tim Wentworth	www.walgreensbootsalliance.com

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.

Walgreens Boots Alliance, Inc. Fundamentals Summary

How do Walgreens Boots Alliance's earnings and revenue compare to its market cap?
WGBA34 fundamental statistics
Market cap	R$78.86b
Earnings (TTM)	-R$30.92b
Revenue (TTM)	R$740.48b

0.1x

P/S Ratio

-2.6x

P/E Ratio

Is WGBA34 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WGBA34 income statement (TTM)
Revenue	US$144.60b
Cost of Revenue	US$117.72b
Gross Profit	US$26.88b
Other Expenses	US$32.91b
Earnings	-US$6.04b

Last Reported Earnings

Feb 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-7.00
Gross Margin	18.59%
Net Profit Margin	-4.18%
Debt/Equity Ratio	61.7%

How did WGBA34 perform over the long term?

See historical performance and comparison

Dividends

5.6%

Current Dividend Yield

-24%

Payout Ratio

WGBA34 Stock Overview

Rewards

Risk Analysis

Walgreens Boots Alliance, Inc. Competitors

BOVESPA:RADL3

R$45.2b

BOVESPA:PNVL3

R$1.8b

BOVESPA:PGMN3

R$1.5b

BOVESPA:CRFB3

R$25.4b

Price History & Performance

Recent News & Updates

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Recent updates

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023

Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc. Announces Resignation of William Foote, the Board Lead Independent Director

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into a definitive agreement to acquire remaining 45% stake in CareCentrix, Inc. for approximately $390 million.

John Standley to Leave as Executive Vice President of Walgreens Boots Alliance, Inc. on November 1, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire additional 30% stake in Shields Specialty Pharmacy Holdings, LLC from Welsh, Carson, Anderson & Stowe, Jack Shields & others for approximately $1.4 billion.

Walgreens Boots Alliance, Inc. to Report Q4, 2022 Results on Oct 13, 2022

Walgreens Boots Alliance, Inc. Announces Executive Appointments

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. Names Alethia Jackson Senior Vice President, ESG and Chief DEI Officer

Walgreens Boots Alliance, Inc. Announces Resignation of David J. Brailer as Member of the Board of Directors

Jnd Legal Administration Announces A Class Action Lawsuit in the U.S. District Court for the District of Arizona Against Defendants Theranos, Inc., Walgreens Boots Alliance, Inc. and Walgreen Arizona Drug Company

Walgreens Boots Alliance Increases Quarterly Dividend, Payable September 9, 2022

Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of Its Successful Boots Business

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Walgreens Boots Alliance, Inc. to Report Q3, 2022 Results on Jun 30, 2022

Walgreens Reportedly Gives A Few Extra Days for Bidders to Firm Up Offers

An unknown buyer acquired 2.9% stake in AmerisourceBergen Corporation (NYSE:ABC) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $900 million.

Walgreens Boots Alliance, Inc. Reaches Opioid Settlement with State of Florida

Walgreens Reportedly Sets Deadline for Bids in Boots Auction

Reliance Industries Reportedly Studying Possible Bid for Walgreens' Boots Chain

Private Equity Giant Reportedly Abandons Boots Takeover

Walgreens Boots Alliance, Inc. Appoints Steven J. Shulman to Its Board of Directors

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 11, 2022

Bain and CVC Reportedly to Team Up for Boots Bid

Oak Street Real Estate Capital, LLC acquired 1.68-acre property at 3600 Winter Garden Vineland Road in Winter Garden from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $5.2 million.

PLx Pharma Inc.’s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from Russell 1000 Defensive Index

Walgreens Boots Alliance, Inc. to Report Q2, 2021 Results on Mar 31, 2021

Walgreens and Uber Technologies, Inc. Enters into an Agreement to Help Drive Equitable Access to COVID-19 Vaccines Among Underserved Communities

Walgreens Boots Alliance, Inc Announces Management Changes Effect from March 15, 2021